The percutaneous coronary intervention market is expanding as cardiovascular disease remains one of the world’s leading health concerns and healthcare systems invest in less invasive cardiac treatment. The market was valued at USD 11.7 billion in 2024 and is projected to grow from USD 12.87 billion in 2025 to USD 33.48 billion by 2035, registering a CAGR of 10.03%. 1058

Percutaneous coronary intervention, commonly known as PCI, includes procedures such as coronary angioplasty and stent placement. These interventions are used in selected patients with narrowed or blocked coronary arteries to improve blood flow to the heart. PCI has become central to modern interventional cardiology because it can provide a less invasive alternative to open-heart surgery in appropriate cases.

Coronary artery disease is the largest application segment, accounting for approximately 46% of market demand. Its strong position reflects the global burden of atherosclerosis, ageing populations, diabetes, hypertension, obesity, smoking, and other cardiovascular risk factors. Acute coronary syndrome is among the fastest-growing segments because emergency cardiac care often requires rapid assessment and intervention.

Stents are the largest device category, representing about 48% of market share. Their purpose is to help maintain vessel patency after angioplasty. Drug-eluting stents are the leading technology segment because they can reduce the risk of restenosis by gradually releasing medication at the treatment site. Bioabsorbable stents are gaining attention as researchers explore materials designed to support vessel healing over time.

Balloon catheters are one of the fastest-growing product segments. Advances in balloon design, catheter flexibility, lesion-crossing capability, and imaging-guided interventions are helping clinicians manage more complex arterial blockages. Guidewires, guiding catheters, sheaths, inflation devices, thrombectomy systems, embolic protection devices, and intravascular imaging systems also play essential roles in the PCI ecosystem.

Hospitals are the largest end-user group, accounting for about 58% of market demand. They provide emergency care, cardiac catheterization labs, imaging, surgical backup, intensive care, and specialist cardiology teams. Cardiac catheterization labs and ambulatory surgical centers are growing as technology enables more efficient and less invasive interventions.

Intravascular ultrasound and optical coherence tomography are improving PCI precision by helping cardiologists assess plaque characteristics, vessel size, stent placement, and treatment outcomes. Artificial intelligence, digital imaging, remote monitoring, and predictive analytics are also expected to support more personalized cardiovascular care.

North America leads the market with more than 51% share, supported by advanced cardiac infrastructure, high healthcare expenditure, and strong adoption of interventional technologies. Europe remains significant, while Asia-Pacific is expected to grow quickly as cardiovascular disease awareness, hospital capacity, and access to minimally invasive procedures improve.

Read more: Percutaneous Coronary Intervention Market 1058

FAQs

Q1. What is percutaneous coronary intervention?
It is a minimally invasive cardiac procedure that may include angioplasty and stent placement to improve coronary blood flow.

Q2. Which device segment leads the PCI market?
Stents lead because they are widely used to help maintain arterial patency after intervention.

Tags: percutaneous coronary intervention, PCI market, coronary stents, angioplasty, interventional cardiology